Literature DB >> 10100642

Polymerization of tau peptides into fibrillar structures. The effect of FTDP-17 mutations.

M Arrasate1, M Pérez, R Armas-Portela, J Avila.   

Abstract

The peptides corresponding to the four repeats found in the microtubule binding region of tau protein were synthesized and their ability for self-aggregation in presence of heparin or chondroitin sulfate was measured. Mainly, only the peptide containing the third tau repeat is able to form polymers in a high proportion. Additionally, the peptide containing the second repeat aggregates with a very low efficiency. However, when this peptide contains the mutation (P301L), described in a fronto temporal dementia, it is able to form polymers at a higher extent. Finally, it is suggested to have a role for the first and fourth tau repeats. It could be to decrease the ability of the third tau repeat for self-aggregation in the presence of heparin.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10100642     DOI: 10.1016/s0014-5793(99)00210-0

Source DB:  PubMed          Journal:  FEBS Lett        ISSN: 0014-5793            Impact factor:   4.124


  31 in total

Review 1.  Protein aggregates and dementia: is there a common toxicity?

Authors:  S Lovestone; D M McLoughlin
Journal:  J Neurol Neurosurg Psychiatry       Date:  2002-02       Impact factor: 10.154

2.  Competition for microtubule-binding with dual expression of tau missense and splice isoforms.

Authors:  M Lu; K S Kosik
Journal:  Mol Biol Cell       Date:  2001-01       Impact factor: 4.138

Review 3.  Tau in Alzheimer disease and related tauopathies.

Authors:  K Iqbal; F Liu; C-X Gong; I Grundke-Iqbal
Journal:  Curr Alzheimer Res       Date:  2010-12       Impact factor: 3.498

Review 4.  Prion-like Spreading in Tauopathies.

Authors:  Jacob I Ayers; Benoit I Giasson; David R Borchelt
Journal:  Biol Psychiatry       Date:  2017-04-13       Impact factor: 13.382

5.  Induction of intracellular tau aggregation is promoted by α-synuclein seeds and provides novel insights into the hyperphosphorylation of tau.

Authors:  Elisa A Waxman; Benoit I Giasson
Journal:  J Neurosci       Date:  2011-05-25       Impact factor: 6.167

6.  Proteasome inhibition drives HDAC6-dependent recruitment of tau to aggresomes.

Authors:  Chris R Guthrie; Brian C Kraemer
Journal:  J Mol Neurosci       Date:  2011-02-22       Impact factor: 3.444

7.  Alzheimer's disease, a multifactorial disorder seeking multitherapies.

Authors:  Khalid Iqbal; Inge Grundke-Iqbal
Journal:  Alzheimers Dement       Date:  2010-09       Impact factor: 21.566

Review 8.  Mechanisms of tau-induced neurodegeneration.

Authors:  Khalid Iqbal; Fei Liu; Cheng-Xin Gong; Alejandra Del C Alonso; Inge Grundke-Iqbal
Journal:  Acta Neuropathol       Date:  2009-01-30       Impact factor: 17.088

Review 9.  Tau function and dysfunction in neurons: its role in neurodegenerative disorders.

Authors:  Jesús Avila; Filip Lim; Francisco Moreno; Carlos Belmonte; A Claudio Cuello
Journal:  Mol Neurobiol       Date:  2002-06       Impact factor: 5.590

10.  FTDP-17 tau mutations induce distinct effects on aggregation and microtubule interactions.

Authors:  Benjamin Combs; T Chris Gamblin
Journal:  Biochemistry       Date:  2012-10-18       Impact factor: 3.162

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.